2015-2027 Global Urological Cancer Drugs Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region
The worldwide market for Urological Cancer Drugs is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Bristol-Myers Squibb
Johnson & Johnson
Novartis
Sanofi S.A.
Tolmar Inc
Astellas
Celgene Corporation
Ipsen
Indevus Pharmaceuticals Inc
AstraZeneca
Pfizer
Abbott Laboratories
Dendreon Corporation
Roche Healthcare
Ferring Pharmaceuticals
GlaxoSmithKline
Major Types Covered
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
Major Applications Covered
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.
Major Companies Covered
Bristol-Myers Squibb
Johnson & Johnson
Novartis
Sanofi S.A.
Tolmar Inc
Astellas
Celgene Corporation
Ipsen
Indevus Pharmaceuticals Inc
AstraZeneca
Pfizer
Abbott Laboratories
Dendreon Corporation
Roche Healthcare
Ferring Pharmaceuticals
GlaxoSmithKline
Major Types Covered
Xofigo (Radium Ra 223 Dichloride)
Jevtana (Cabazitaxel)
Inlyta (Axitinib)
Votrient (Pazopanib Hydrochloride)
Sutent (Sunitinib Malate)
Zytiga (Abiraterone Acetate)
Xtandi (Enzalutamide)
Opdivo (Nivolumab)
Provenge (Sipuleucel-T)
Major Applications Covered
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027
1 INTRODUCTION
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Urological Cancer Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Urological Cancer Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE UROLOGICAL CANCER DRUGS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY TYPE
5.1 Xofigo (Radium Ra 223 Dichloride)
5.2 Jevtana (Cabazitaxel)
5.3 Inlyta (Axitinib)
5.4 Votrient (Pazopanib Hydrochloride)
5.5 Sutent (Sunitinib Malate)
5.6 Zytiga (Abiraterone Acetate)
5.7 Xtandi (Enzalutamide)
5.8 Opdivo (Nivolumab)
5.9 Provenge (Sipuleucel-T)
6 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY APPLICATION
6.1 Prostate Cancer
6.2 Bladder Cancer
6.3 Kidney Cancer
6.4 Testicular Cancer
7 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb Profile
8.1.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
8.1.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Profile
8.2.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.2.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.3 Novartis
8.3.1 Novartis Profile
8.3.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Novartis Product/Solution Launches and Enhancements Analysis
8.3.4 Novartis Business Overview/Recent Development/Acquisitions
8.4 Sanofi S.A.
8.4.1 Sanofi S.A. Profile
8.4.2 Sanofi S.A. Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Sanofi S.A. Product/Solution Launches and Enhancements Analysis
8.4.4 Sanofi S.A. Business Overview/Recent Development/Acquisitions
8.5 Tolmar Inc
8.5.1 Tolmar Inc Profile
8.5.2 Tolmar Inc Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Tolmar Inc Product/Solution Launches and Enhancements Analysis
8.5.4 Tolmar Inc Business Overview/Recent Development/Acquisitions
8.6 Astellas
8.6.1 Astellas Profile
8.6.2 Astellas Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Astellas Product/Solution Launches and Enhancements Analysis
8.6.4 Astellas Business Overview/Recent Development/Acquisitions
8.7 Celgene Corporation
8.7.1 Celgene Corporation Profile
8.7.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
8.7.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.8 Ipsen
8.8.1 Ipsen Profile
8.8.2 Ipsen Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Ipsen Product/Solution Launches and Enhancements Analysis
8.8.4 Ipsen Business Overview/Recent Development/Acquisitions
8.9 Indevus Pharmaceuticals Inc
8.9.1 Indevus Pharmaceuticals Inc Profile
8.9.2 Indevus Pharmaceuticals Inc Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Indevus Pharmaceuticals Inc Product/Solution Launches and Enhancements Analysis
8.9.4 Indevus Pharmaceuticals Inc Business Overview/Recent Development/Acquisitions
8.10 AstraZeneca
8.10.1 AstraZeneca Profile
8.10.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.10.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.11 Pfizer
8.11.1 Pfizer Profile
8.11.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.11.4 Pfizer Business Overview/Recent Development/Acquisitions
8.12 Abbott Laboratories
8.12.1 Abbott Laboratories Profile
8.12.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Abbott Laboratories Product/Solution Launches and Enhancements Analysis
8.12.4 Abbott Laboratories Business Overview/Recent Development/Acquisitions
8.13 Dendreon Corporation
8.13.1 Dendreon Corporation Profile
8.13.2 Dendreon Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Dendreon Corporation Product/Solution Launches and Enhancements Analysis
8.13.4 Dendreon Corporation Business Overview/Recent Development/Acquisitions
8.14 Roche Healthcare
8.14.1 Roche Healthcare Profile
8.14.2 Roche Healthcare Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Roche Healthcare Product/Solution Launches and Enhancements Analysis
8.14.4 Roche Healthcare Business Overview/Recent Development/Acquisitions
8.15 Ferring Pharmaceuticals
8.15.1 Ferring Pharmaceuticals Profile
8.15.2 Ferring Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Ferring Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.15.4 Ferring Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.16 GlaxoSmithKline
8.16.1 GlaxoSmithKline Profile
8.16.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.16.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
9 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Urological Cancer Drugs Production Analysis from 2015-2020
10.4 North America Urological Cancer Drugs Consumption Analysis from 2015-2020
10.5 North America Urological Cancer Drugs Import and Export from 2015-2020
10.6 North America Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Urological Cancer Drugs by Country (United States, Canada)
10.8.1 North America Urological Cancer Drugs Sales by Country (2015-2020)
10.8.2 North America Urological Cancer Drugs Consumption Value by Country (2015-2020)
10.9 North America Urological Cancer Drugs Market PEST Analysis
11 EUROPE
11.1 Europe Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Urological Cancer Drugs Production Analysis from 2015-2020
11.4 Europe Urological Cancer Drugs Consumption Analysis from 2015-2020
11.5 Europe Urological Cancer Drugs Import and Export from 2015-2020
11.6 Europe Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Urological Cancer Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Urological Cancer Drugs Sales by Country (2015-2020)
11.8.2 Europe Urological Cancer Drugs Consumption Value by Country (2015-2020)
11.9 Europe Urological Cancer Drugs Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Urological Cancer Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Urological Cancer Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Urological Cancer Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Urological Cancer Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Urological Cancer Drugs Sales by Country (2015-2020)
12.8.2 Asia-Pacific Urological Cancer Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Urological Cancer Drugs Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Urological Cancer Drugs Production Analysis from 2015-2020
13.4 Latin America Urological Cancer Drugs Consumption Analysis from 2015-2020
13.5 Latin America Urological Cancer Drugs Import and Export from 2015-2020
13.6 Latin America Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Urological Cancer Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Urological Cancer Drugs Sales by Country (2015-2020)
13.8.2 Latin America Urological Cancer Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Urological Cancer Drugs Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Urological Cancer Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Urological Cancer Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Urological Cancer Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Urological Cancer Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Urological Cancer Drugs Sales by Country (2015-2020)
14.8.2 Middle East & Africa Urological Cancer Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Urological Cancer Drugs Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL UROLOGICAL CANCER DRUGS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Urological Cancer Drugs Market from 2020-2027 Segment by Region
15.2 Global Urological Cancer Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
1.3.1 Market Segment by Type, Application and Marketing Channel
1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders
2 KEY FINDINGS OF THE STUDY
3 MARKET DYNAMICS
3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Urological Cancer Drugs Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Urological Cancer Drugs Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis
4 VALUE CHAIN OF THE UROLOGICAL CANCER DRUGS MARKET
4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)
5 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY TYPE
5.1 Xofigo (Radium Ra 223 Dichloride)
5.2 Jevtana (Cabazitaxel)
5.3 Inlyta (Axitinib)
5.4 Votrient (Pazopanib Hydrochloride)
5.5 Sutent (Sunitinib Malate)
5.6 Zytiga (Abiraterone Acetate)
5.7 Xtandi (Enzalutamide)
5.8 Opdivo (Nivolumab)
5.9 Provenge (Sipuleucel-T)
6 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY APPLICATION
6.1 Prostate Cancer
6.2 Bladder Cancer
6.3 Kidney Cancer
6.4 Testicular Cancer
7 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY MARKETING CHANNEL
7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel
8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES
8.1 Bristol-Myers Squibb
8.1.1 Bristol-Myers Squibb Profile
8.1.2 Bristol-Myers Squibb Sales, Growth Rate and Global Market Share from 2015-2020
8.1.3 Bristol-Myers Squibb Product/Solution Launches and Enhancements Analysis
8.1.4 Bristol-Myers Squibb Business Overview/Recent Development/Acquisitions
8.2 Johnson & Johnson
8.2.1 Johnson & Johnson Profile
8.2.2 Johnson & Johnson Sales, Growth Rate and Global Market Share from 2015-2020
8.2.3 Johnson & Johnson Product/Solution Launches and Enhancements Analysis
8.2.4 Johnson & Johnson Business Overview/Recent Development/Acquisitions
8.3 Novartis
8.3.1 Novartis Profile
8.3.2 Novartis Sales, Growth Rate and Global Market Share from 2015-2020
8.3.3 Novartis Product/Solution Launches and Enhancements Analysis
8.3.4 Novartis Business Overview/Recent Development/Acquisitions
8.4 Sanofi S.A.
8.4.1 Sanofi S.A. Profile
8.4.2 Sanofi S.A. Sales, Growth Rate and Global Market Share from 2015-2020
8.4.3 Sanofi S.A. Product/Solution Launches and Enhancements Analysis
8.4.4 Sanofi S.A. Business Overview/Recent Development/Acquisitions
8.5 Tolmar Inc
8.5.1 Tolmar Inc Profile
8.5.2 Tolmar Inc Sales, Growth Rate and Global Market Share from 2015-2020
8.5.3 Tolmar Inc Product/Solution Launches and Enhancements Analysis
8.5.4 Tolmar Inc Business Overview/Recent Development/Acquisitions
8.6 Astellas
8.6.1 Astellas Profile
8.6.2 Astellas Sales, Growth Rate and Global Market Share from 2015-2020
8.6.3 Astellas Product/Solution Launches and Enhancements Analysis
8.6.4 Astellas Business Overview/Recent Development/Acquisitions
8.7 Celgene Corporation
8.7.1 Celgene Corporation Profile
8.7.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.7.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
8.7.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.8 Ipsen
8.8.1 Ipsen Profile
8.8.2 Ipsen Sales, Growth Rate and Global Market Share from 2015-2020
8.8.3 Ipsen Product/Solution Launches and Enhancements Analysis
8.8.4 Ipsen Business Overview/Recent Development/Acquisitions
8.9 Indevus Pharmaceuticals Inc
8.9.1 Indevus Pharmaceuticals Inc Profile
8.9.2 Indevus Pharmaceuticals Inc Sales, Growth Rate and Global Market Share from 2015-2020
8.9.3 Indevus Pharmaceuticals Inc Product/Solution Launches and Enhancements Analysis
8.9.4 Indevus Pharmaceuticals Inc Business Overview/Recent Development/Acquisitions
8.10 AstraZeneca
8.10.1 AstraZeneca Profile
8.10.2 AstraZeneca Sales, Growth Rate and Global Market Share from 2015-2020
8.10.3 AstraZeneca Product/Solution Launches and Enhancements Analysis
8.10.4 AstraZeneca Business Overview/Recent Development/Acquisitions
8.11 Pfizer
8.11.1 Pfizer Profile
8.11.2 Pfizer Sales, Growth Rate and Global Market Share from 2015-2020
8.11.3 Pfizer Product/Solution Launches and Enhancements Analysis
8.11.4 Pfizer Business Overview/Recent Development/Acquisitions
8.12 Abbott Laboratories
8.12.1 Abbott Laboratories Profile
8.12.2 Abbott Laboratories Sales, Growth Rate and Global Market Share from 2015-2020
8.12.3 Abbott Laboratories Product/Solution Launches and Enhancements Analysis
8.12.4 Abbott Laboratories Business Overview/Recent Development/Acquisitions
8.13 Dendreon Corporation
8.13.1 Dendreon Corporation Profile
8.13.2 Dendreon Corporation Sales, Growth Rate and Global Market Share from 2015-2020
8.13.3 Dendreon Corporation Product/Solution Launches and Enhancements Analysis
8.13.4 Dendreon Corporation Business Overview/Recent Development/Acquisitions
8.14 Roche Healthcare
8.14.1 Roche Healthcare Profile
8.14.2 Roche Healthcare Sales, Growth Rate and Global Market Share from 2015-2020
8.14.3 Roche Healthcare Product/Solution Launches and Enhancements Analysis
8.14.4 Roche Healthcare Business Overview/Recent Development/Acquisitions
8.15 Ferring Pharmaceuticals
8.15.1 Ferring Pharmaceuticals Profile
8.15.2 Ferring Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
8.15.3 Ferring Pharmaceuticals Product/Solution Launches and Enhancements Analysis
8.15.4 Ferring Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.16 GlaxoSmithKline
8.16.1 GlaxoSmithKline Profile
8.16.2 GlaxoSmithKline Sales, Growth Rate and Global Market Share from 2015-2020
8.16.3 GlaxoSmithKline Product/Solution Launches and Enhancements Analysis
8.16.4 GlaxoSmithKline Business Overview/Recent Development/Acquisitions
9 GLOBAL UROLOGICAL CANCER DRUGS MARKET-SEGMENTATION BY GEOGRAPHY
10 NORTH AMERICA
10.1 North America Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Urological Cancer Drugs Production Analysis from 2015-2020
10.4 North America Urological Cancer Drugs Consumption Analysis from 2015-2020
10.5 North America Urological Cancer Drugs Import and Export from 2015-2020
10.6 North America Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
10.7 North America Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Urological Cancer Drugs by Country (United States, Canada)
10.8.1 North America Urological Cancer Drugs Sales by Country (2015-2020)
10.8.2 North America Urological Cancer Drugs Consumption Value by Country (2015-2020)
10.9 North America Urological Cancer Drugs Market PEST Analysis
11 EUROPE
11.1 Europe Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Urological Cancer Drugs Production Analysis from 2015-2020
11.4 Europe Urological Cancer Drugs Consumption Analysis from 2015-2020
11.5 Europe Urological Cancer Drugs Import and Export from 2015-2020
11.6 Europe Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
11.7 Europe Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Urological Cancer Drugs by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
11.8.1 Europe Urological Cancer Drugs Sales by Country (2015-2020)
11.8.2 Europe Urological Cancer Drugs Consumption Value by Country (2015-2020)
11.9 Europe Urological Cancer Drugs Market PEST Analysis
12 ASIA-PACIFIC
12.1 Asia-Pacific Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Urological Cancer Drugs Production Analysis from 2015-2020
12.4 Asia-Pacific Urological Cancer Drugs Consumption Analysis from 2015-2020
12.5 Asia-Pacific Urological Cancer Drugs Import and Export from 2015-2020
12.6 Asia-Pacific Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Urological Cancer Drugs by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
12.8.1 Asia-Pacific Urological Cancer Drugs Sales by Country (2015-2020)
12.8.2 Asia-Pacific Urological Cancer Drugs Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Urological Cancer Drugs Market PEST Analysis
13 LATIN AMERICA
13.1 Latin America Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Urological Cancer Drugs Production Analysis from 2015-2020
13.4 Latin America Urological Cancer Drugs Consumption Analysis from 2015-2020
13.5 Latin America Urological Cancer Drugs Import and Export from 2015-2020
13.6 Latin America Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Urological Cancer Drugs by Country (Brazil, Mexico, Argentina, Columbia, Chile)
13.8.1 Latin America Urological Cancer Drugs Sales by Country (2015-2020)
13.8.2 Latin America Urological Cancer Drugs Consumption Value by Country (2015-2020)
13.9 Latin America Urological Cancer Drugs Market PEST Analysis
14 MIDDLE EAST & AFRICA
14.1 Middle East & Africa Urological Cancer Drugs Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Urological Cancer Drugs Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Urological Cancer Drugs Production Analysis from 2015-2020
14.4 Middle East & Africa Urological Cancer Drugs Consumption Analysis from 2015-2020
14.5 Middle East & Africa Urological Cancer Drugs Import and Export from 2015-2020
14.6 Middle East & Africa Urological Cancer Drugs Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Urological Cancer Drugs Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Urological Cancer Drugs by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
14.8.1 Middle East & Africa Urological Cancer Drugs Sales by Country (2015-2020)
14.8.2 Middle East & Africa Urological Cancer Drugs Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Urological Cancer Drugs Market PEST Analysis
15 FUTURE FORECAST OF THE GLOBAL UROLOGICAL CANCER DRUGS MARKET FROM 2020-2027
15.1 Future Forecast of the Global Urological Cancer Drugs Market from 2020-2027 Segment by Region
15.2 Global Urological Cancer Drugs Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Application (2020-2027)
16 APPENDIX
16.1 Methodology
16.2 Research Data Source
LIST OF TABLES AND FIGURES
Global Urological Cancer Drugs Market Value ($) and Growth Rate of Urological Cancer Drugs from 2015-2027
Global Urological Cancer Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Urological Cancer Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Urological Cancer Drugs Picture
Table Product Specifications of Urological Cancer Drugs
Table Driving Factors for this Market
Table Industry News of Urological Cancer Drugs Market
Figure Value Chain Status of Urological Cancer Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Urological Cancer Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Xofigo (Radium Ra 223 Dichloride) of Urological Cancer Drugs
Figure Jevtana (Cabazitaxel) of Urological Cancer Drugs
Figure Inlyta (Axitinib) of Urological Cancer Drugs
Figure Votrient (Pazopanib Hydrochloride) of Urological Cancer Drugs
Figure Sutent (Sunitinib Malate) of Urological Cancer Drugs
Figure Zytiga (Abiraterone Acetate) of Urological Cancer Drugs
Figure Xtandi (Enzalutamide) of Urological Cancer Drugs
Figure Opdivo (Nivolumab) of Urological Cancer Drugs
Figure Provenge (Sipuleucel-T) of Urological Cancer Drugs
Table Global Urological Cancer Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Prostate Cancer of Urological Cancer Drugs
Figure Bladder Cancer of Urological Cancer Drugs
Figure Kidney Cancer of Urological Cancer Drugs
Figure Testicular Cancer of Urological Cancer Drugs
Table Global Urological Cancer Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Urological Cancer Drugs
Figure Online Channel of Urological Cancer Drugs
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi S.A. Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi S.A. Sales and Growth Rate from 2015-2020
Figure Sanofi S.A. Revenue ($) and Global Market Share from 2015-2020
Table Sanofi S.A. Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Tolmar Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Tolmar Inc Sales and Growth Rate from 2015-2020
Figure Tolmar Inc Revenue ($) and Global Market Share from 2015-2020
Table Tolmar Inc Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astellas Profile (Company Name, Plants Distribution, Sales Region)
Figure Astellas Sales and Growth Rate from 2015-2020
Figure Astellas Revenue ($) and Global Market Share from 2015-2020
Table Astellas Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Celgene Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Celgene Corporation Sales and Growth Rate from 2015-2020
Figure Celgene Corporation Revenue ($) and Global Market Share from 2015-2020
Table Celgene Corporation Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ipsen Profile (Company Name, Plants Distribution, Sales Region)
Figure Ipsen Sales and Growth Rate from 2015-2020
Figure Ipsen Revenue ($) and Global Market Share from 2015-2020
Table Ipsen Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Indevus Pharmaceuticals Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Indevus Pharmaceuticals Inc Sales and Growth Rate from 2015-2020
Figure Indevus Pharmaceuticals Inc Revenue ($) and Global Market Share from 2015-2020
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Laboratories Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Laboratories Sales and Growth Rate from 2015-2020
Figure Abbott Laboratories Revenue ($) and Global Market Share from 2015-2020
Table Abbott Laboratories Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dendreon Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Dendreon Corporation Sales and Growth Rate from 2015-2020
Figure Dendreon Corporation Revenue ($) and Global Market Share from 2015-2020
Table Dendreon Corporation Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Healthcare Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Healthcare Sales and Growth Rate from 2015-2020
Figure Roche Healthcare Revenue ($) and Global Market Share from 2015-2020
Table Roche Healthcare Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ferring Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ferring Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Ferring Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Ferring Pharmaceuticals Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Urological Cancer Drugs Production Value ($) by Region from 2015-2020
Table Global Urological Cancer Drugs Production Value Share by Region from 2015-2020
Table Global Urological Cancer Drugs Production by Region from 2015-2020
Table Global Urological Cancer Drugs Consumption Value ($) by Region from 2015-2020
Table Global Urological Cancer Drugs Consumption by Region from 2015-2020
Table North America Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Urological Cancer Drugs Import and Export from 2015-2020
Table North America Urological Cancer Drugs Value ($) by Type (2015-2020)
Table North America Urological Cancer Drugs Production by Type (2015-2020)
Table North America Urological Cancer Drugs Consumption by Application (2015-2020)
Table North America Urological Cancer Drugs Consumption by Country (2015-2020)
Table North America Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Urological Cancer Drugs Market PEST Analysis
Table Europe Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Urological Cancer Drugs Import and Export from 2015-2020
Table Europe Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Europe Urological Cancer Drugs Production by Type (2015-2020)
Table Europe Urological Cancer Drugs Consumption by Application (2015-2020)
Table Europe Urological Cancer Drugs Consumption by Country (2015-2020)
Table Europe Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Urological Cancer Drugs Market PEST Analysis
Table Asia-Pacific Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Import and Export from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Production by Type (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market PEST Analysis
Table Latin America Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Urological Cancer Drugs Import and Export from 2015-2020
Table Latin America Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Latin America Urological Cancer Drugs Production by Type (2015-2020)
Table Latin America Urological Cancer Drugs Consumption by Application (2015-2020)
Table Latin America Urological Cancer Drugs Consumption by Country (2015-2020)
Table Latin America Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Urological Cancer Drugs Market PEST Analysis
Table Middle East & Africa Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Import and Export from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Production by Type (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Urological Cancer Drugs Market PEST Analysis
Table Global Urological Cancer Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Application (2020-2027)
Global Urological Cancer Drugs Market Value ($) and Growth Rate of Urological Cancer Drugs from 2015-2027
Global Urological Cancer Drugs Production and Growth Rate Segment by Product Type from 2015-2027
Global Urological Cancer Drugs Consumption and Growth Rate Segment by Application from 2015-2027
Figure Urological Cancer Drugs Picture
Table Product Specifications of Urological Cancer Drugs
Table Driving Factors for this Market
Table Industry News of Urological Cancer Drugs Market
Figure Value Chain Status of Urological Cancer Drugs
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Urological Cancer Drugs Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Xofigo (Radium Ra 223 Dichloride) of Urological Cancer Drugs
Figure Jevtana (Cabazitaxel) of Urological Cancer Drugs
Figure Inlyta (Axitinib) of Urological Cancer Drugs
Figure Votrient (Pazopanib Hydrochloride) of Urological Cancer Drugs
Figure Sutent (Sunitinib Malate) of Urological Cancer Drugs
Figure Zytiga (Abiraterone Acetate) of Urological Cancer Drugs
Figure Xtandi (Enzalutamide) of Urological Cancer Drugs
Figure Opdivo (Nivolumab) of Urological Cancer Drugs
Figure Provenge (Sipuleucel-T) of Urological Cancer Drugs
Table Global Urological Cancer Drugs Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Prostate Cancer of Urological Cancer Drugs
Figure Bladder Cancer of Urological Cancer Drugs
Figure Kidney Cancer of Urological Cancer Drugs
Figure Testicular Cancer of Urological Cancer Drugs
Table Global Urological Cancer Drugs Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Urological Cancer Drugs Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Urological Cancer Drugs
Figure Online Channel of Urological Cancer Drugs
Table Bristol-Myers Squibb Profile (Company Name, Plants Distribution, Sales Region)
Figure Bristol-Myers Squibb Sales and Growth Rate from 2015-2020
Figure Bristol-Myers Squibb Revenue ($) and Global Market Share from 2015-2020
Table Bristol-Myers Squibb Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Johnson & Johnson Profile (Company Name, Plants Distribution, Sales Region)
Figure Johnson & Johnson Sales and Growth Rate from 2015-2020
Figure Johnson & Johnson Revenue ($) and Global Market Share from 2015-2020
Table Johnson & Johnson Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Novartis Profile (Company Name, Plants Distribution, Sales Region)
Figure Novartis Sales and Growth Rate from 2015-2020
Figure Novartis Revenue ($) and Global Market Share from 2015-2020
Table Novartis Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Sanofi S.A. Profile (Company Name, Plants Distribution, Sales Region)
Figure Sanofi S.A. Sales and Growth Rate from 2015-2020
Figure Sanofi S.A. Revenue ($) and Global Market Share from 2015-2020
Table Sanofi S.A. Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Tolmar Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Tolmar Inc Sales and Growth Rate from 2015-2020
Figure Tolmar Inc Revenue ($) and Global Market Share from 2015-2020
Table Tolmar Inc Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Astellas Profile (Company Name, Plants Distribution, Sales Region)
Figure Astellas Sales and Growth Rate from 2015-2020
Figure Astellas Revenue ($) and Global Market Share from 2015-2020
Table Astellas Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Celgene Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Celgene Corporation Sales and Growth Rate from 2015-2020
Figure Celgene Corporation Revenue ($) and Global Market Share from 2015-2020
Table Celgene Corporation Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ipsen Profile (Company Name, Plants Distribution, Sales Region)
Figure Ipsen Sales and Growth Rate from 2015-2020
Figure Ipsen Revenue ($) and Global Market Share from 2015-2020
Table Ipsen Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Indevus Pharmaceuticals Inc Profile (Company Name, Plants Distribution, Sales Region)
Figure Indevus Pharmaceuticals Inc Sales and Growth Rate from 2015-2020
Figure Indevus Pharmaceuticals Inc Revenue ($) and Global Market Share from 2015-2020
Table Indevus Pharmaceuticals Inc Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table AstraZeneca Profile (Company Name, Plants Distribution, Sales Region)
Figure AstraZeneca Sales and Growth Rate from 2015-2020
Figure AstraZeneca Revenue ($) and Global Market Share from 2015-2020
Table AstraZeneca Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Pfizer Profile (Company Name, Plants Distribution, Sales Region)
Figure Pfizer Sales and Growth Rate from 2015-2020
Figure Pfizer Revenue ($) and Global Market Share from 2015-2020
Table Pfizer Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Abbott Laboratories Profile (Company Name, Plants Distribution, Sales Region)
Figure Abbott Laboratories Sales and Growth Rate from 2015-2020
Figure Abbott Laboratories Revenue ($) and Global Market Share from 2015-2020
Table Abbott Laboratories Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Dendreon Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Dendreon Corporation Sales and Growth Rate from 2015-2020
Figure Dendreon Corporation Revenue ($) and Global Market Share from 2015-2020
Table Dendreon Corporation Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Roche Healthcare Profile (Company Name, Plants Distribution, Sales Region)
Figure Roche Healthcare Sales and Growth Rate from 2015-2020
Figure Roche Healthcare Revenue ($) and Global Market Share from 2015-2020
Table Roche Healthcare Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Ferring Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure Ferring Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure Ferring Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table Ferring Pharmaceuticals Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline Urological Cancer Drugs Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Urological Cancer Drugs Production Value ($) by Region from 2015-2020
Table Global Urological Cancer Drugs Production Value Share by Region from 2015-2020
Table Global Urological Cancer Drugs Production by Region from 2015-2020
Table Global Urological Cancer Drugs Consumption Value ($) by Region from 2015-2020
Table Global Urological Cancer Drugs Consumption by Region from 2015-2020
Table North America Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Urological Cancer Drugs Import and Export from 2015-2020
Table North America Urological Cancer Drugs Value ($) by Type (2015-2020)
Table North America Urological Cancer Drugs Production by Type (2015-2020)
Table North America Urological Cancer Drugs Consumption by Application (2015-2020)
Table North America Urological Cancer Drugs Consumption by Country (2015-2020)
Table North America Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure North America Urological Cancer Drugs Market PEST Analysis
Table Europe Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Urological Cancer Drugs Import and Export from 2015-2020
Table Europe Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Europe Urological Cancer Drugs Production by Type (2015-2020)
Table Europe Urological Cancer Drugs Consumption by Application (2015-2020)
Table Europe Urological Cancer Drugs Consumption by Country (2015-2020)
Table Europe Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Europe Urological Cancer Drugs Market PEST Analysis
Table Asia-Pacific Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Import and Export from 2015-2020
Table Asia-Pacific Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Production by Type (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption by Application (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption by Country (2015-2020)
Table Asia-Pacific Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Urological Cancer Drugs Market PEST Analysis
Table Latin America Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Urological Cancer Drugs Import and Export from 2015-2020
Table Latin America Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Latin America Urological Cancer Drugs Production by Type (2015-2020)
Table Latin America Urological Cancer Drugs Consumption by Application (2015-2020)
Table Latin America Urological Cancer Drugs Consumption by Country (2015-2020)
Table Latin America Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Latin America Urological Cancer Drugs Market PEST Analysis
Table Middle East & Africa Urological Cancer Drugs Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Import and Export from 2015-2020
Table Middle East & Africa Urological Cancer Drugs Value ($) by Type (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Production by Type (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption by Application (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption by Country (2015-2020)
Table Middle East & Africa Urological Cancer Drugs Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Urological Cancer Drugs Market PEST Analysis
Table Global Urological Cancer Drugs Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Production and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Urological Cancer Drugs Production and Growth Rate Forecast by Type (2020-2027)
Table Global Urological Cancer Drugs Consumption and Growth Rate Forecast by Application (2020-2027)
